nodes	percent_of_prediction	percent_of_DWPC	metapath
Bisacodyl—GPR55—Signaling by GPCR—ADORA1—coronary artery disease	0.00137	0.00278	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—ADORA3—coronary artery disease	0.00137	0.00278	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—HTR7—coronary artery disease	0.00137	0.00278	CbGpPWpGaD
Bisacodyl—Loss of consciousness—Enalapril—coronary artery disease	0.00133	0.00262	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—PPBP—coronary artery disease	0.00132	0.00269	CbGpPWpGaD
Bisacodyl—Anaphylactic shock—Olmesartan—coronary artery disease	0.00132	0.00261	CcSEcCtD
Bisacodyl—Angioedema—Captopril—coronary artery disease	0.00132	0.00261	CcSEcCtD
Bisacodyl—Muscle spasms—Furosemide—coronary artery disease	0.00131	0.00259	CcSEcCtD
Bisacodyl—Hypersensitivity—Rosuvastatin—coronary artery disease	0.00131	0.00258	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Clopidogrel—coronary artery disease	0.00131	0.00258	CcSEcCtD
Bisacodyl—Shock—Valsartan—coronary artery disease	0.00131	0.00258	CcSEcCtD
Bisacodyl—Loss of consciousness—Telmisartan—coronary artery disease	0.00131	0.00258	CcSEcCtD
Bisacodyl—Dizziness—Ticagrelor—coronary artery disease	0.00131	0.00257	CcSEcCtD
Bisacodyl—Nervous system disorder—Valsartan—coronary artery disease	0.0013	0.00257	CcSEcCtD
Bisacodyl—Shock—Olmesartan—coronary artery disease	0.0013	0.00257	CcSEcCtD
Bisacodyl—GPR55—GPCR ligand binding—KNG1—coronary artery disease	0.0013	0.00264	CbGpPWpGaD
Bisacodyl—Nervous system disorder—Olmesartan—coronary artery disease	0.0013	0.00256	CcSEcCtD
Bisacodyl—Syncope—Captopril—coronary artery disease	0.0013	0.00256	CcSEcCtD
Bisacodyl—Anaphylactic shock—Niacin—coronary artery disease	0.00129	0.00255	CcSEcCtD
Bisacodyl—GPR55—GPCR ligand binding—AGTR1—coronary artery disease	0.00129	0.00262	CbGpPWpGaD
Bisacodyl—Vomiting—Gemfibrozil—coronary artery disease	0.00129	0.00253	CcSEcCtD
Bisacodyl—Angioedema—Perindopril—coronary artery disease	0.00128	0.00253	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—AVPR1A—coronary artery disease	0.00128	0.0026	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—ADM2—coronary artery disease	0.00128	0.0026	CbGpPWpGaD
Bisacodyl—Gastrointestinal disorder—Ezetimibe—coronary artery disease	0.00128	0.00251	CcSEcCtD
Bisacodyl—Anaphylactic shock—Pravastatin—coronary artery disease	0.00127	0.00251	CcSEcCtD
Bisacodyl—Shock—Niacin—coronary artery disease	0.00127	0.00251	CcSEcCtD
Bisacodyl—Loss of consciousness—Captopril—coronary artery disease	0.00127	0.00251	CcSEcCtD
Bisacodyl—Hypersensitivity—Acetylsalicylic acid—coronary artery disease	0.00127	0.00251	CcSEcCtD
Bisacodyl—Muscle spasms—Losartan—coronary artery disease	0.00127	0.0025	CcSEcCtD
Bisacodyl—Headache—Gemfibrozil—coronary artery disease	0.00127	0.0025	CcSEcCtD
Bisacodyl—GPR55—G alpha (i) signalling events—POMC—coronary artery disease	0.00126	0.00257	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—CXCL10—coronary artery disease	0.00126	0.00256	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CCL4—coronary artery disease	0.00126	0.00256	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—OPRD1—coronary artery disease	0.00126	0.00256	CbGpPWpGaD
Bisacodyl—Gastrointestinal pain—Fenofibrate—coronary artery disease	0.00126	0.00249	CcSEcCtD
Bisacodyl—Syncope—Perindopril—coronary artery disease	0.00126	0.00249	CcSEcCtD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—HTR2A—coronary artery disease	0.00126	0.00256	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—C3—coronary artery disease	0.00126	0.00255	CbGpPWpGaD
Bisacodyl—Vomiting—Ticagrelor—coronary artery disease	0.00126	0.00248	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Eplerenone—coronary artery disease	0.00125	0.00246	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Clopidogrel—coronary artery disease	0.00124	0.00244	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—UTS2—coronary artery disease	0.00124	0.00252	CbGpPWpGaD
Bisacodyl—Headache—Ticagrelor—coronary artery disease	0.00124	0.00244	CcSEcCtD
Bisacodyl—Loss of consciousness—Perindopril—coronary artery disease	0.00124	0.00244	CcSEcCtD
Bisacodyl—Anaphylactic shock—Enalapril—coronary artery disease	0.00123	0.00243	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Lovastatin—coronary artery disease	0.00123	0.00243	CcSEcCtD
Bisacodyl—GPR55—GPCR ligand binding—ADRB2—coronary artery disease	0.00123	0.00249	CbGpPWpGaD
Bisacodyl—Abdominal pain—Fenofibrate—coronary artery disease	0.00122	0.0024	CcSEcCtD
Bisacodyl—Shock—Trandolapril—coronary artery disease	0.00122	0.0024	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Simvastatin—coronary artery disease	0.00122	0.0024	CcSEcCtD
Bisacodyl—Diarrhoea—Rosuvastatin—coronary artery disease	0.00122	0.0024	CcSEcCtD
Bisacodyl—Anaphylactic shock—Telmisartan—coronary artery disease	0.00122	0.0024	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—TMED2—coronary artery disease	0.00121	0.00246	CbGpPWpGaD
Bisacodyl—Nervous system disorder—Trandolapril—coronary artery disease	0.00121	0.00239	CcSEcCtD
Bisacodyl—Shock—Enalapril—coronary artery disease	0.00121	0.00239	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Ezetimibe—coronary artery disease	0.00121	0.00238	CcSEcCtD
Bisacodyl—Angioedema—Losartan—coronary artery disease	0.0012	0.00238	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—P2RY12—coronary artery disease	0.0012	0.00244	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—PLCB3—coronary artery disease	0.0012	0.00244	CbGpPWpGaD
Bisacodyl—Nausea—Gemfibrozil—coronary artery disease	0.0012	0.00237	CcSEcCtD
Bisacodyl—Abdominal pain—Clopidogrel—coronary artery disease	0.0012	0.00236	CcSEcCtD
Bisacodyl—Shock—Telmisartan—coronary artery disease	0.0012	0.00236	CcSEcCtD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—AGT—coronary artery disease	0.00119	0.00242	CbGpPWpGaD
Bisacodyl—Nervous system disorder—Telmisartan—coronary artery disease	0.00119	0.00235	CcSEcCtD
Bisacodyl—Abdominal pain—Lovastatin—coronary artery disease	0.00119	0.00235	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—CASR—coronary artery disease	0.00119	0.00241	CbGpPWpGaD
Bisacodyl—Gastrointestinal pain—Eplerenone—coronary artery disease	0.00118	0.00233	CcSEcCtD
Bisacodyl—Syncope—Losartan—coronary artery disease	0.00118	0.00233	CcSEcCtD
Bisacodyl—Anaphylactic shock—Captopril—coronary artery disease	0.00118	0.00233	CcSEcCtD
Bisacodyl—Diarrhoea—Acetylsalicylic acid—coronary artery disease	0.00118	0.00233	CcSEcCtD
Bisacodyl—Dizziness—Rosuvastatin—coronary artery disease	0.00118	0.00232	CcSEcCtD
Bisacodyl—Immune system disorder—Ramipril—coronary artery disease	0.00117	0.00231	CcSEcCtD
Bisacodyl—Nausea—Ticagrelor—coronary artery disease	0.00117	0.00231	CcSEcCtD
Bisacodyl—Abdominal pain—Ezetimibe—coronary artery disease	0.00117	0.0023	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—AVPR1A—coronary artery disease	0.00117	0.00237	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—BDKRB1—coronary artery disease	0.00117	0.00237	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—GNA12—coronary artery disease	0.00117	0.00237	CbGpPWpGaD
Bisacodyl—Shock—Captopril—coronary artery disease	0.00116	0.00229	CcSEcCtD
Bisacodyl—Loss of consciousness—Losartan—coronary artery disease	0.00116	0.00228	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—LRP8—coronary artery disease	0.00116	0.00235	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—DGKZ—coronary artery disease	0.00116	0.00235	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—RLN3—coronary artery disease	0.00116	0.00235	CbGpPWpGaD
Bisacodyl—Gastrointestinal pain—Simvastatin—coronary artery disease	0.00115	0.00227	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Valsartan—coronary artery disease	0.00115	0.00226	CcSEcCtD
Bisacodyl—Anaphylactic shock—Perindopril—coronary artery disease	0.00115	0.00226	CcSEcCtD
Bisacodyl—Immune system disorder—Timolol—coronary artery disease	0.00115	0.00226	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Olmesartan—coronary artery disease	0.00114	0.00225	CcSEcCtD
Bisacodyl—Abdominal pain—Eplerenone—coronary artery disease	0.00114	0.00225	CcSEcCtD
Bisacodyl—Dizziness—Acetylsalicylic acid—coronary artery disease	0.00114	0.00225	CcSEcCtD
Bisacodyl—Hypersensitivity—Fenofibrate—coronary artery disease	0.00114	0.00224	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—ADM—coronary artery disease	0.00113	0.0023	CbGpPWpGaD
Bisacodyl—Malnutrition—Ramipril—coronary artery disease	0.00113	0.00223	CcSEcCtD
Bisacodyl—Shock—Perindopril—coronary artery disease	0.00113	0.00223	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—UTS2—coronary artery disease	0.00113	0.00228	CbGpPWpGaD
Bisacodyl—Nervous system disorder—Perindopril—coronary artery disease	0.00113	0.00222	CcSEcCtD
Bisacodyl—Hypersensitivity—Clopidogrel—coronary artery disease	0.00112	0.0022	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Niacin—coronary artery disease	0.00112	0.0022	CcSEcCtD
Bisacodyl—Anaphylactic shock—Furosemide—coronary artery disease	0.00112	0.0022	CcSEcCtD
Bisacodyl—Abdominal pain—Simvastatin—coronary artery disease	0.00111	0.0022	CcSEcCtD
Bisacodyl—Headache—Rosuvastatin—coronary artery disease	0.00111	0.0022	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—AES—coronary artery disease	0.00111	0.00225	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—EDN2—coronary artery disease	0.00111	0.00225	CbGpPWpGaD
Bisacodyl—Hypersensitivity—Lovastatin—coronary artery disease	0.00111	0.00219	CcSEcCtD
Bisacodyl—Malnutrition—Timolol—coronary artery disease	0.00111	0.00218	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—PDE4B—coronary artery disease	0.00111	0.00224	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—F2—coronary artery disease	0.0011	0.00224	CbGpPWpGaD
Bisacodyl—Vomiting—Acetylsalicylic acid—coronary artery disease	0.0011	0.00216	CcSEcCtD
Bisacodyl—Shock—Furosemide—coronary artery disease	0.0011	0.00216	CcSEcCtD
Bisacodyl—GPR55—GPCR ligand binding—EDN1—coronary artery disease	0.0011	0.00222	CbGpPWpGaD
Bisacodyl—Nervous system disorder—Furosemide—coronary artery disease	0.00109	0.00216	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—PLCB3—coronary artery disease	0.00109	0.00221	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—P2RY12—coronary artery disease	0.00109	0.00221	CbGpPWpGaD
Bisacodyl—Hypersensitivity—Ezetimibe—coronary artery disease	0.00109	0.00215	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Valsartan—coronary artery disease	0.00109	0.00215	CcSEcCtD
Bisacodyl—GPR55—GPCR ligand binding—CCL5—coronary artery disease	0.00109	0.00221	CbGpPWpGaD
Bisacodyl—Muscle spasms—Ramipril—coronary artery disease	0.00109	0.00214	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Olmesartan—coronary artery disease	0.00108	0.00213	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—CASR—coronary artery disease	0.00108	0.00219	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CX3CR1—coronary artery disease	0.00108	0.00219	CbGpPWpGaD
Bisacodyl—Anaphylactic shock—Losartan—coronary artery disease	0.00108	0.00212	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—HRH2—coronary artery disease	0.00107	0.00217	CbGpPWpGaD
Bisacodyl—Gastrointestinal disorder—Trandolapril—coronary artery disease	0.00107	0.00211	CcSEcCtD
Bisacodyl—Shock—Losartan—coronary artery disease	0.00106	0.00209	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—BDKRB1—coronary artery disease	0.00106	0.00215	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CX3CL1—coronary artery disease	0.00106	0.00215	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—GNA12—coronary artery disease	0.00106	0.00215	CbGpPWpGaD
Bisacodyl—Gastrointestinal pain—Niacin—coronary artery disease	0.00106	0.00209	CcSEcCtD
Bisacodyl—Nausea—Rosuvastatin—coronary artery disease	0.00106	0.00208	CcSEcCtD
Bisacodyl—Diarrhoea—Fenofibrate—coronary artery disease	0.00106	0.00208	CcSEcCtD
Bisacodyl—Nervous system disorder—Losartan—coronary artery disease	0.00106	0.00208	CcSEcCtD
Bisacodyl—Abdominal pain—Valsartan—coronary artery disease	0.00105	0.00207	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Telmisartan—coronary artery disease	0.00105	0.00207	CcSEcCtD
Bisacodyl—Abdominal pain—Olmesartan—coronary artery disease	0.00105	0.00206	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Pravastatin—coronary artery disease	0.00104	0.00205	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—PPP3R1—coronary artery disease	0.00104	0.00211	CbGpPWpGaD
Bisacodyl—Hypersensitivity—Simvastatin—coronary artery disease	0.00104	0.00205	CcSEcCtD
Bisacodyl—Diarrhoea—Clopidogrel—coronary artery disease	0.00104	0.00205	CcSEcCtD
Bisacodyl—Angioedema—Ramipril—coronary artery disease	0.00103	0.00204	CcSEcCtD
Bisacodyl—Diarrhoea—Lovastatin—coronary artery disease	0.00103	0.00203	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—ADM—coronary artery disease	0.00103	0.00209	CbGpPWpGaD
Bisacodyl—Nausea—Acetylsalicylic acid—coronary artery disease	0.00103	0.00202	CcSEcCtD
Bisacodyl—Malnutrition—Lisinopril—coronary artery disease	0.00103	0.00202	CcSEcCtD
Bisacodyl—Abdominal pain—Niacin—coronary artery disease	0.00102	0.00202	CcSEcCtD
Bisacodyl—Dizziness—Fenofibrate—coronary artery disease	0.00102	0.00201	CcSEcCtD
Bisacodyl—Syncope—Ramipril—coronary artery disease	0.00101	0.002	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Trandolapril—coronary artery disease	0.00101	0.00199	CcSEcCtD
Bisacodyl—Diarrhoea—Ezetimibe—coronary artery disease	0.00101	0.00199	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—CCR3—coronary artery disease	0.00101	0.00205	CbGpPWpGaD
Bisacodyl—Angioedema—Timolol—coronary artery disease	0.00101	0.00199	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Enalapril—coronary artery disease	0.00101	0.00199	CcSEcCtD
Bisacodyl—Abdominal pain—Pravastatin—coronary artery disease	0.00101	0.00199	CcSEcCtD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—POMC—coronary artery disease	0.00101	0.00204	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—PDE4B—coronary artery disease	0.001	0.00204	CbGpPWpGaD
Bisacodyl—Dizziness—Clopidogrel—coronary artery disease	0.001	0.00198	CcSEcCtD
Bisacodyl—Dizziness—Lovastatin—coronary artery disease	0.000996	0.00196	CcSEcCtD
Bisacodyl—Loss of consciousness—Ramipril—coronary artery disease	0.000994	0.00196	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Telmisartan—coronary artery disease	0.000994	0.00196	CcSEcCtD
Bisacodyl—Syncope—Timolol—coronary artery disease	0.000991	0.00195	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Perindopril—coronary artery disease	0.00099	0.00195	CcSEcCtD
Bisacodyl—Diarrhoea—Eplerenone—coronary artery disease	0.000989	0.00195	CcSEcCtD
Bisacodyl—Muscle spasms—Lisinopril—coronary artery disease	0.000986	0.00194	CcSEcCtD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—CCL2—coronary artery disease	0.000984	0.002	CbGpPWpGaD
Bisacodyl—Vomiting—Fenofibrate—coronary artery disease	0.000981	0.00193	CcSEcCtD
Bisacodyl—Hypersensitivity—Valsartan—coronary artery disease	0.00098	0.00193	CcSEcCtD
Bisacodyl—GPR55—G alpha (i) signalling events—CXCL8—coronary artery disease	0.000978	0.00199	CbGpPWpGaD
Bisacodyl—Abdominal pain—Trandolapril—coronary artery disease	0.000978	0.00193	CcSEcCtD
Bisacodyl—Dizziness—Ezetimibe—coronary artery disease	0.000977	0.00193	CcSEcCtD
Bisacodyl—Abdominal pain—Enalapril—coronary artery disease	0.000974	0.00192	CcSEcCtD
Bisacodyl—Loss of consciousness—Timolol—coronary artery disease	0.000971	0.00192	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—RHOC—coronary artery disease	0.00097	0.00197	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—ACVR1B—coronary artery disease	0.00097	0.00197	CbGpPWpGaD
Bisacodyl—Headache—Fenofibrate—coronary artery disease	0.000966	0.00191	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Captopril—coronary artery disease	0.000966	0.00191	CcSEcCtD
Bisacodyl—Vomiting—Clopidogrel—coronary artery disease	0.000964	0.0019	CcSEcCtD
Bisacodyl—Diarrhoea—Simvastatin—coronary artery disease	0.000964	0.0019	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Furosemide—coronary artery disease	0.000963	0.0019	CcSEcCtD
Bisacodyl—Abdominal pain—Telmisartan—coronary artery disease	0.000961	0.00189	CcSEcCtD
Bisacodyl—GPR55—GPCR ligand binding—HTR2A—coronary artery disease	0.000959	0.00195	CbGpPWpGaD
Bisacodyl—Vomiting—Lovastatin—coronary artery disease	0.000958	0.00189	CcSEcCtD
Bisacodyl—GPR55—GPCR ligand binding—C3—coronary artery disease	0.000958	0.00194	CbGpPWpGaD
Bisacodyl—Dizziness—Eplerenone—coronary artery disease	0.000956	0.00189	CcSEcCtD
Bisacodyl—Hypersensitivity—Niacin—coronary artery disease	0.000953	0.00188	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—CXCL2—coronary artery disease	0.00095	0.00193	CbGpPWpGaD
Bisacodyl—Headache—Clopidogrel—coronary artery disease	0.00095	0.00187	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—NEDD4—coronary artery disease	0.000944	0.00192	CbGpPWpGaD
Bisacodyl—Headache—Lovastatin—coronary artery disease	0.000944	0.00186	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—F2R—coronary artery disease	0.00094	0.00191	CbGpPWpGaD
Bisacodyl—Vomiting—Ezetimibe—coronary artery disease	0.000939	0.00185	CcSEcCtD
Bisacodyl—Hypersensitivity—Pravastatin—coronary artery disease	0.000938	0.00185	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Perindopril—coronary artery disease	0.000938	0.00185	CcSEcCtD
Bisacodyl—Angioedema—Lisinopril—coronary artery disease	0.000937	0.00185	CcSEcCtD
Bisacodyl—Abdominal pain—Captopril—coronary artery disease	0.000934	0.00184	CcSEcCtD
Bisacodyl—Dizziness—Simvastatin—coronary artery disease	0.000932	0.00184	CcSEcCtD
Bisacodyl—Headache—Ezetimibe—coronary artery disease	0.000926	0.00182	CcSEcCtD
Bisacodyl—Anaphylactic shock—Ramipril—coronary artery disease	0.000923	0.00182	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—MDK—coronary artery disease	0.00092	0.00187	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PDE3A—coronary artery disease	0.00092	0.00187	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PF4—coronary artery disease	0.00092	0.00187	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—RAMP2—coronary artery disease	0.00092	0.00187	CbGpPWpGaD
Bisacodyl—Syncope—Lisinopril—coronary artery disease	0.000919	0.00181	CcSEcCtD
Bisacodyl—Vomiting—Eplerenone—coronary artery disease	0.000919	0.00181	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—CCR3—coronary artery disease	0.000918	0.00186	CbGpPWpGaD
Bisacodyl—Nausea—Fenofibrate—coronary artery disease	0.000916	0.00181	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Furosemide—coronary artery disease	0.000912	0.0018	CcSEcCtD
Bisacodyl—Hypersensitivity—Trandolapril—coronary artery disease	0.000911	0.0018	CcSEcCtD
Bisacodyl—Diarrhoea—Valsartan—coronary artery disease	0.00091	0.00179	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—EDNRB—coronary artery disease	0.00091	0.00185	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—AGT—coronary artery disease	0.00091	0.00185	CbGpPWpGaD
Bisacodyl—Shock—Ramipril—coronary artery disease	0.000908	0.00179	CcSEcCtD
Bisacodyl—Hypersensitivity—Enalapril—coronary artery disease	0.000908	0.00179	CcSEcCtD
Bisacodyl—Abdominal pain—Perindopril—coronary artery disease	0.000907	0.00179	CcSEcCtD
Bisacodyl—Diarrhoea—Olmesartan—coronary artery disease	0.000906	0.00179	CcSEcCtD
Bisacodyl—Headache—Eplerenone—coronary artery disease	0.000906	0.00179	CcSEcCtD
Bisacodyl—Nervous system disorder—Ramipril—coronary artery disease	0.000905	0.00178	CcSEcCtD
Bisacodyl—Anaphylactic shock—Timolol—coronary artery disease	0.000902	0.00178	CcSEcCtD
Bisacodyl—Loss of consciousness—Lisinopril—coronary artery disease	0.000901	0.00178	CcSEcCtD
Bisacodyl—Nausea—Clopidogrel—coronary artery disease	0.000901	0.00178	CcSEcCtD
Bisacodyl—Vomiting—Simvastatin—coronary artery disease	0.000896	0.00177	CcSEcCtD
Bisacodyl—Hypersensitivity—Telmisartan—coronary artery disease	0.000895	0.00177	CcSEcCtD
Bisacodyl—Nausea—Lovastatin—coronary artery disease	0.000895	0.00176	CcSEcCtD
Bisacodyl—Shock—Timolol—coronary artery disease	0.000887	0.00175	CcSEcCtD
Bisacodyl—Diarrhoea—Niacin—coronary artery disease	0.000885	0.00175	CcSEcCtD
Bisacodyl—Nervous system disorder—Timolol—coronary artery disease	0.000885	0.00174	CcSEcCtD
Bisacodyl—Headache—Simvastatin—coronary artery disease	0.000883	0.00174	CcSEcCtD
Bisacodyl—Abdominal pain—Furosemide—coronary artery disease	0.000882	0.00174	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Losartan—coronary artery disease	0.00088	0.00173	CcSEcCtD
Bisacodyl—Dizziness—Valsartan—coronary artery disease	0.00088	0.00173	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—RALBP1—coronary artery disease	0.000878	0.00178	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—NPY5R—coronary artery disease	0.000878	0.00178	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—F2RL1—coronary artery disease	0.000878	0.00178	CbGpPWpGaD
Bisacodyl—Nausea—Ezetimibe—coronary artery disease	0.000878	0.00173	CcSEcCtD
Bisacodyl—Dizziness—Olmesartan—coronary artery disease	0.000876	0.00173	CcSEcCtD
Bisacodyl—Diarrhoea—Pravastatin—coronary artery disease	0.000871	0.00172	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—CXCL2—coronary artery disease	0.000863	0.00175	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CCL3—coronary artery disease	0.000863	0.00175	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—EDNRA—coronary artery disease	0.000859	0.00174	CbGpPWpGaD
Bisacodyl—Nausea—Eplerenone—coronary artery disease	0.000859	0.00169	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—ADRB1—coronary artery disease	0.000856	0.00174	CbGpPWpGaD
Bisacodyl—Dizziness—Niacin—coronary artery disease	0.000855	0.00169	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—F2R—coronary artery disease	0.000853	0.00173	CbGpPWpGaD
Bisacodyl—Abdominal pain—Losartan—coronary artery disease	0.000851	0.00168	CcSEcCtD
Bisacodyl—Diarrhoea—Trandolapril—coronary artery disease	0.000846	0.00167	CcSEcCtD
Bisacodyl—Vomiting—Valsartan—coronary artery disease	0.000846	0.00167	CcSEcCtD
Bisacodyl—Diarrhoea—Enalapril—coronary artery disease	0.000843	0.00166	CcSEcCtD
Bisacodyl—Dizziness—Pravastatin—coronary artery disease	0.000842	0.00166	CcSEcCtD
Bisacodyl—Vomiting—Olmesartan—coronary artery disease	0.000842	0.00166	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—FZD2—coronary artery disease	0.000841	0.00171	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—UTS2R—coronary artery disease	0.000841	0.00171	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—F2—coronary artery disease	0.000841	0.00171	CbGpPWpGaD
Bisacodyl—Nausea—Simvastatin—coronary artery disease	0.000837	0.00165	CcSEcCtD
Bisacodyl—Anaphylactic shock—Lisinopril—coronary artery disease	0.000837	0.00165	CcSEcCtD
Bisacodyl—Headache—Valsartan—coronary artery disease	0.000833	0.00164	CcSEcCtD
Bisacodyl—Diarrhoea—Telmisartan—coronary artery disease	0.000831	0.00164	CcSEcCtD
Bisacodyl—Headache—Olmesartan—coronary artery disease	0.000829	0.00164	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—EDNRB—coronary artery disease	0.000826	0.00168	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—SFRP2—coronary artery disease	0.000825	0.00167	CbGpPWpGaD
Bisacodyl—Shock—Lisinopril—coronary artery disease	0.000823	0.00162	CcSEcCtD
Bisacodyl—Vomiting—Niacin—coronary artery disease	0.000823	0.00162	CcSEcCtD
Bisacodyl—Hypersensitivity—Furosemide—coronary artery disease	0.000822	0.00162	CcSEcCtD
Bisacodyl—Dizziness—Trandolapril—coronary artery disease	0.000818	0.00161	CcSEcCtD
Bisacodyl—Dizziness—Enalapril—coronary artery disease	0.000815	0.00161	CcSEcCtD
Bisacodyl—Headache—Niacin—coronary artery disease	0.00081	0.0016	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—APOA4—coronary artery disease	0.00081	0.00164	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—ADORA1—coronary artery disease	0.00081	0.00164	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—ADORA3—coronary artery disease	0.00081	0.00164	CbGpPWpGaD
Bisacodyl—Vomiting—Pravastatin—coronary artery disease	0.00081	0.0016	CcSEcCtD
Bisacodyl—Diarrhoea—Captopril—coronary artery disease	0.000808	0.00159	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—CXCL12—coronary artery disease	0.000808	0.00164	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—BDKRB2—coronary artery disease	0.000808	0.00164	CbGpPWpGaD
Bisacodyl—Dizziness—Telmisartan—coronary artery disease	0.000804	0.00158	CcSEcCtD
Bisacodyl—Headache—Pravastatin—coronary artery disease	0.000798	0.00157	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Ramipril—coronary artery disease	0.000797	0.00157	CcSEcCtD
Bisacodyl—Hypersensitivity—Losartan—coronary artery disease	0.000793	0.00156	CcSEcCtD
Bisacodyl—Nausea—Valsartan—coronary artery disease	0.00079	0.00156	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—PLCB1—coronary artery disease	0.00079	0.0016	CbGpPWpGaD
Bisacodyl—Nausea—Olmesartan—coronary artery disease	0.000786	0.00155	CcSEcCtD
Bisacodyl—Vomiting—Trandolapril—coronary artery disease	0.000786	0.00155	CcSEcCtD
Bisacodyl—Diarrhoea—Perindopril—coronary artery disease	0.000785	0.00155	CcSEcCtD
Bisacodyl—Vomiting—Enalapril—coronary artery disease	0.000783	0.00154	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—PGF—coronary artery disease	0.000782	0.00159	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PPBP—coronary artery disease	0.000782	0.00159	CbGpPWpGaD
Bisacodyl—Dizziness—Captopril—coronary artery disease	0.000781	0.00154	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—EDNRA—coronary artery disease	0.00078	0.00158	CbGpPWpGaD
Bisacodyl—Gastrointestinal disorder—Timolol—coronary artery disease	0.000779	0.00154	CcSEcCtD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—CXCL8—coronary artery disease	0.000778	0.00158	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—ADRB1—coronary artery disease	0.000777	0.00158	CbGpPWpGaD
Bisacodyl—Headache—Trandolapril—coronary artery disease	0.000775	0.00153	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—HTR7—coronary artery disease	0.000774	0.00157	CbGpPWpGaD
Bisacodyl—Vomiting—Telmisartan—coronary artery disease	0.000773	0.00152	CcSEcCtD
Bisacodyl—Headache—Enalapril—coronary artery disease	0.000772	0.00152	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—DVL1—coronary artery disease	0.00077	0.00156	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—ITGA2B—coronary artery disease	0.00077	0.00156	CbGpPWpGaD
Bisacodyl—Nausea—Niacin—coronary artery disease	0.000768	0.00152	CcSEcCtD
Bisacodyl—GPR55—GPCR ligand binding—POMC—coronary artery disease	0.000766	0.00155	CbGpPWpGaD
Bisacodyl—Diarrhoea—Furosemide—coronary artery disease	0.000763	0.0015	CcSEcCtD
Bisacodyl—Headache—Telmisartan—coronary artery disease	0.000761	0.0015	CcSEcCtD
Bisacodyl—Dizziness—Perindopril—coronary artery disease	0.000759	0.0015	CcSEcCtD
Bisacodyl—Nausea—Pravastatin—coronary artery disease	0.000757	0.00149	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Ramipril—coronary artery disease	0.000754	0.00149	CcSEcCtD
Bisacodyl—Vomiting—Captopril—coronary artery disease	0.000751	0.00148	CcSEcCtD
Bisacodyl—GPR55—GPCR ligand binding—CCL2—coronary artery disease	0.000749	0.00152	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—OPRD1—coronary artery disease	0.000746	0.00151	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—GHR—coronary artery disease	0.000746	0.00151	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CCL4—coronary artery disease	0.000746	0.00151	CbGpPWpGaD
Bisacodyl—Headache—Captopril—coronary artery disease	0.00074	0.00146	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Timolol—coronary artery disease	0.000738	0.00145	CcSEcCtD
Bisacodyl—Dizziness—Furosemide—coronary artery disease	0.000737	0.00145	CcSEcCtD
Bisacodyl—Diarrhoea—Losartan—coronary artery disease	0.000736	0.00145	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—KNG1—coronary artery disease	0.000735	0.00149	CbGpPWpGaD
Bisacodyl—Nausea—Trandolapril—coronary artery disease	0.000735	0.00145	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—BDKRB2—coronary artery disease	0.000734	0.00149	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CXCL12—coronary artery disease	0.000734	0.00149	CbGpPWpGaD
Bisacodyl—Nausea—Enalapril—coronary artery disease	0.000732	0.00144	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—AGTR1—coronary artery disease	0.000731	0.00148	CbGpPWpGaD
Bisacodyl—Vomiting—Perindopril—coronary artery disease	0.000729	0.00144	CcSEcCtD
Bisacodyl—Abdominal pain—Ramipril—coronary artery disease	0.000729	0.00144	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Lisinopril—coronary artery disease	0.000722	0.00142	CcSEcCtD
Bisacodyl—Nausea—Telmisartan—coronary artery disease	0.000722	0.00142	CcSEcCtD
Bisacodyl—Headache—Perindopril—coronary artery disease	0.000719	0.00142	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—PLCB1—coronary artery disease	0.000718	0.00146	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—TLE4—coronary artery disease	0.000715	0.00145	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—MEF2A—coronary artery disease	0.000715	0.00145	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—CXCL10—coronary artery disease	0.000714	0.00145	CbGpPWpGaD
Bisacodyl—Abdominal pain—Timolol—coronary artery disease	0.000713	0.00141	CcSEcCtD
Bisacodyl—Dizziness—Losartan—coronary artery disease	0.000712	0.0014	CcSEcCtD
Bisacodyl—Vomiting—Furosemide—coronary artery disease	0.000709	0.0014	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—HTR7—coronary artery disease	0.000703	0.00143	CbGpPWpGaD
Bisacodyl—Nausea—Captopril—coronary artery disease	0.000702	0.00138	CcSEcCtD
Bisacodyl—Headache—Furosemide—coronary artery disease	0.000699	0.00138	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—APOA2—coronary artery disease	0.000697	0.00141	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—ADRB2—coronary artery disease	0.000693	0.00141	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—AVPR1A—coronary artery disease	0.000689	0.0014	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—PRKCE—coronary artery disease	0.000684	0.00139	CbGpPWpGaD
Bisacodyl—Gastrointestinal pain—Lisinopril—coronary artery disease	0.000684	0.00135	CcSEcCtD
Bisacodyl—Vomiting—Losartan—coronary artery disease	0.000684	0.00135	CcSEcCtD
Bisacodyl—Nausea—Perindopril—coronary artery disease	0.000681	0.00134	CcSEcCtD
Bisacodyl—Hypersensitivity—Ramipril—coronary artery disease	0.00068	0.00134	CcSEcCtD
Bisacodyl—Headache—Losartan—coronary artery disease	0.000674	0.00133	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—KNG1—coronary artery disease	0.000668	0.00135	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—UTS2—coronary artery disease	0.000665	0.00135	CbGpPWpGaD
Bisacodyl—Hypersensitivity—Timolol—coronary artery disease	0.000665	0.00131	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—AGTR1—coronary artery disease	0.000664	0.00135	CbGpPWpGaD
Bisacodyl—Nausea—Furosemide—coronary artery disease	0.000662	0.00131	CcSEcCtD
Bisacodyl—Abdominal pain—Lisinopril—coronary artery disease	0.000661	0.0013	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—NR4A1—coronary artery disease	0.000651	0.00132	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CXCL10—coronary artery disease	0.000648	0.00132	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—P2RY12—coronary artery disease	0.000644	0.00131	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—HDAC9—coronary artery disease	0.000644	0.00131	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PLCB3—coronary artery disease	0.000644	0.00131	CbGpPWpGaD
Bisacodyl—Nausea—Losartan—coronary artery disease	0.000639	0.00126	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—CASR—coronary artery disease	0.000638	0.00129	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CX3CR1—coronary artery disease	0.000638	0.00129	CbGpPWpGaD
Bisacodyl—Diarrhoea—Ramipril—coronary artery disease	0.000631	0.00124	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—ADRB2—coronary artery disease	0.00063	0.00128	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—GNA12—coronary artery disease	0.000625	0.00127	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—P4HB—coronary artery disease	0.000625	0.00127	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—BDKRB1—coronary artery disease	0.000625	0.00127	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CX3CL1—coronary artery disease	0.000625	0.00127	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—PRKCE—coronary artery disease	0.000622	0.00126	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—EDN1—coronary artery disease	0.000619	0.00126	CbGpPWpGaD
Bisacodyl—Diarrhoea—Timolol—coronary artery disease	0.000617	0.00122	CcSEcCtD
Bisacodyl—Hypersensitivity—Lisinopril—coronary artery disease	0.000617	0.00122	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—CCL5—coronary artery disease	0.000615	0.00125	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PPP3R1—coronary artery disease	0.000614	0.00125	CbGpPWpGaD
Bisacodyl—Dizziness—Ramipril—coronary artery disease	0.00061	0.0012	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—ADM—coronary artery disease	0.000608	0.00123	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—CSF2—coronary artery disease	0.000605	0.00123	CbGpPWpGaD
Bisacodyl—Dizziness—Timolol—coronary artery disease	0.000596	0.00118	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—CYBB—coronary artery disease	0.000593	0.0012	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PDE4B—coronary artery disease	0.000593	0.0012	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—CXCL8—coronary artery disease	0.000592	0.0012	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—MMP3—coronary artery disease	0.000591	0.0012	CbGpPWpGaD
Bisacodyl—Vomiting—Ramipril—coronary artery disease	0.000587	0.00116	CcSEcCtD
Bisacodyl—Headache—Ramipril—coronary artery disease	0.000578	0.00114	CcSEcCtD
Bisacodyl—Vomiting—Timolol—coronary artery disease	0.000574	0.00113	CcSEcCtD
Bisacodyl—Diarrhoea—Lisinopril—coronary artery disease	0.000573	0.00113	CcSEcCtD
Bisacodyl—Headache—Timolol—coronary artery disease	0.000565	0.00111	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—EDN1—coronary artery disease	0.000563	0.00114	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CCL5—coronary artery disease	0.000558	0.00113	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—PRKCD—coronary artery disease	0.000554	0.00112	CbGpPWpGaD
Bisacodyl—Dizziness—Lisinopril—coronary artery disease	0.000553	0.00109	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—CSF2—coronary artery disease	0.00055	0.00112	CbGpPWpGaD
Bisacodyl—Nausea—Ramipril—coronary artery disease	0.000548	0.00108	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—CCR3—coronary artery disease	0.000542	0.0011	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—HTR2A—coronary artery disease	0.000542	0.0011	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—C3—coronary artery disease	0.000541	0.0011	CbGpPWpGaD
Bisacodyl—Nausea—Timolol—coronary artery disease	0.000536	0.00106	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—CRK—coronary artery disease	0.000535	0.00109	CbGpPWpGaD
Bisacodyl—Vomiting—Lisinopril—coronary artery disease	0.000532	0.00105	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—SH2B3—coronary artery disease	0.000528	0.00107	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—ATP2A2—coronary artery disease	0.000528	0.00107	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—VWF—coronary artery disease	0.000528	0.00107	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—APOC3—coronary artery disease	0.000525	0.00107	CbGpPWpGaD
Bisacodyl—Headache—Lisinopril—coronary artery disease	0.000524	0.00103	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—LDLR—coronary artery disease	0.000522	0.00106	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—AGT—coronary artery disease	0.000514	0.00104	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—PPP2CA—coronary artery disease	0.000512	0.00104	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CCL3—coronary artery disease	0.00051	0.00103	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CXCL2—coronary artery disease	0.00051	0.00103	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—F2R—coronary artery disease	0.000504	0.00102	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—SDC1—coronary artery disease	0.000504	0.00102	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—PRKCD—coronary artery disease	0.000503	0.00102	CbGpPWpGaD
Bisacodyl—Nausea—Lisinopril—coronary artery disease	0.000497	0.00098	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—FGB—coronary artery disease	0.000493	0.001	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—HTR2A—coronary artery disease	0.000492	0.000999	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—C3—coronary artery disease	0.000491	0.000997	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—EDNRB—coronary artery disease	0.000488	0.000991	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—THBS1—coronary artery disease	0.000481	0.000976	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PSMA6—coronary artery disease	0.000476	0.000966	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PSMB5—coronary artery disease	0.000476	0.000966	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—F2—coronary artery disease	0.000475	0.000964	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—AGT—coronary artery disease	0.000467	0.000947	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—EDNRA—coronary artery disease	0.000461	0.000935	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CYBA—coronary artery disease	0.000459	0.000931	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—ADRB1—coronary artery disease	0.000459	0.000931	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—DUSP6—coronary artery disease	0.000457	0.000927	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PLAT—coronary artery disease	0.000449	0.000912	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CXCL12—coronary artery disease	0.000433	0.000879	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—BDKRB2—coronary artery disease	0.000433	0.000879	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—POMC—coronary artery disease	0.000433	0.000878	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—F2—coronary artery disease	0.000431	0.000875	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—IL6ST—coronary artery disease	0.00043	0.000872	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—JUNB—coronary artery disease	0.000425	0.000863	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PLCB1—coronary artery disease	0.000424	0.00086	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—HTR7—coronary artery disease	0.000415	0.000842	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—ITGAV—coronary artery disease	0.000396	0.000803	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—KNG1—coronary artery disease	0.000394	0.0008	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—POMC—coronary artery disease	0.000393	0.000797	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CREB1—coronary artery disease	0.000393	0.000797	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—AGTR1—coronary artery disease	0.000392	0.000795	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CCL2—coronary artery disease	0.000385	0.00078	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—IL6R—coronary artery disease	0.000383	0.000778	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CXCL10—coronary artery disease	0.000383	0.000777	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PLG—coronary artery disease	0.000382	0.000775	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—ADRB2—coronary artery disease	0.000372	0.000755	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PRKCE—coronary artery disease	0.000367	0.000745	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—JAK2—coronary artery disease	0.000367	0.000744	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—SOCS1—coronary artery disease	0.000366	0.000743	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—S100B—coronary artery disease	0.000365	0.000741	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—SOCS3—coronary artery disease	0.000362	0.000734	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—KITLG—coronary artery disease	0.000357	0.000725	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—TGFBR2—coronary artery disease	0.000357	0.000725	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—MMP3—coronary artery disease	0.000349	0.000709	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—STAT5A—coronary artery disease	0.000349	0.000709	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—APOB—coronary artery disease	0.000338	0.000685	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—CXCL8—coronary artery disease	0.000335	0.000679	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—JAK2—coronary artery disease	0.000333	0.000676	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—EDN1—coronary artery disease	0.000332	0.000674	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CCL5—coronary artery disease	0.00033	0.000669	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CSF2—coronary artery disease	0.000325	0.000659	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—FGF1—coronary artery disease	0.000325	0.000659	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—LPL—coronary artery disease	0.000322	0.000654	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—RPS6KB1—coronary artery disease	0.00032	0.000648	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—MEF2C—coronary artery disease	0.00032	0.000648	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—ITGB3—coronary artery disease	0.000311	0.000632	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CXCL8—coronary artery disease	0.000304	0.000617	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PPP2CA—coronary artery disease	0.000303	0.000614	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PRKCD—coronary artery disease	0.000297	0.000603	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—HTR2A—coronary artery disease	0.000291	0.00059	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—C3—coronary artery disease	0.00029	0.000589	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—HIF1A—coronary artery disease	0.000277	0.000562	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—AGT—coronary artery disease	0.000276	0.00056	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—LEP—coronary artery disease	0.00027	0.000548	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—APOE—coronary artery disease	0.00027	0.000548	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—APOA1—coronary artery disease	0.000267	0.000542	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—KDR—coronary artery disease	0.000265	0.000537	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—MAPK14—coronary artery disease	0.000263	0.000534	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—ESR1—coronary artery disease	0.000258	0.000524	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—F2—coronary artery disease	0.000255	0.000517	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—FN1—coronary artery disease	0.000255	0.000517	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—IL6ST—coronary artery disease	0.000254	0.000515	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—NFKBIA—coronary artery disease	0.000252	0.000511	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—KIT—coronary artery disease	0.000244	0.000495	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—GSK3B—coronary artery disease	0.000234	0.000475	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—POMC—coronary artery disease	0.000232	0.000471	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CREB1—coronary artery disease	0.000232	0.000471	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CCL2—coronary artery disease	0.000227	0.000461	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—IL6R—coronary artery disease	0.000226	0.00046	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—IGF1—coronary artery disease	0.000223	0.000453	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—MAPK1—coronary artery disease	0.000222	0.000451	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—PIK3CA—coronary artery disease	0.000212	0.000431	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—SERPINE1—coronary artery disease	0.000212	0.00043	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—FGF2—coronary artery disease	0.000205	0.000417	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—NOS3—coronary artery disease	0.000202	0.000411	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—JAK2—coronary artery disease	0.000197	0.000399	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—PIK3CA—coronary artery disease	0.000193	0.000391	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CXCL8—coronary artery disease	0.00018	0.000364	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—AKT1—coronary artery disease	0.000174	0.000352	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CASP3—coronary artery disease	0.000172	0.000349	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—IL6—coronary artery disease	0.000171	0.000347	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CCND1—coronary artery disease	0.000167	0.00034	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—MMP9—coronary artery disease	0.000162	0.00033	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—AKT1—coronary artery disease	0.000158	0.00032	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—VEGFA—coronary artery disease	0.000146	0.000296	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—TGFB1—coronary artery disease	0.000134	0.000272	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—MAPK1—coronary artery disease	0.000131	0.000266	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PIK3CA—coronary artery disease	0.000114	0.000231	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—IL6—coronary artery disease	0.000101	0.000205	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—AKT1—coronary artery disease	9.31e-05	0.000189	CbGpPWpGaD
